Patents by Inventor Seetharamulu Peddaiaghari

Seetharamulu Peddaiaghari has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of treating diabetic ophthalmopathy
    Patent number: 6274622
    Abstract: This invention relates to a method of treating patients afflicted with diabetic ophthalmopathy. The method includes administering to a patient in need of treatment an effective amount of a thiol or reducible disulfide compound according to the formula set forth in the specification.
    Type: Grant
    Filed: October 27, 1999
    Date of Patent: August 14, 2001
    Inventors: Frederick H. Hausheer, Aulma Parker, Seetharamulu Peddaiaghari
  • Method of treating diabetic angiopathy
    Patent number: 6251881
    Abstract: This invention relates to a method of treating patients afflicted with diabetic angiopathy. The method includes administering to a patient in need of treatment an effective amount of a thiol or reducible disulfide compound according to the formula set forth in the specification.
    Type: Grant
    Filed: October 21, 1999
    Date of Patent: June 26, 2001
    Inventors: Frederick H. Hausheer, Aulma Parker, Seetharamulu Peddaiaghari
  • Method of treating diabetic neuropathy
    Patent number: 6100247
    Abstract: This invention relates to a method of treating patients afflicted with diabetic neuropathy. The method includes administering to a patient in need of treatment an effective amount of a thiol or reducible disulfide compound according to the formula set forth in the specification.
    Type: Grant
    Filed: October 21, 1999
    Date of Patent: August 8, 2000
    Assignee: BioNumerik Pharmaceuticals, Inc.
    Inventors: Frederick H. Hausheer, Aulma Parker, Seetharamulu Peddaiaghari
  • Method of treating diabetic nephropathy
    Patent number: 6031006
    Abstract: This invention relates to a method of treating patients afflicted with diabetic nephropathy. The method includes administering to a patient in need of treatment an effective amount of a thiol or reducible disulfide compound according to the formula set forth in the specification.
    Type: Grant
    Filed: October 21, 1999
    Date of Patent: February 29, 2000
    Assignee: BioNumerik Pharmaceuticals, Inc.
    Inventors: Frederick H. Hausheer, Aulma Parker, Seetharamulu Peddaiaghari